Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,856
datasets available to search
ShareScore release 0.9.0
Dataset results
5,856 results for “B cells”
Safety Analysis of Intravenous Rapid Infusion of Obinutuzumab in Patients With B-cell Non-Hodgkin's Lymphoma in China
ClinicalTrials.gov study NCT05510219. IPD Sharing: Not stated. Countries: 1. Publications: 0.
This is a Phase 1 Study of MH048 in Patients With Selected Relapsed/Refractory B-cell Malignancies
ClinicalTrials.gov study NCT04689308. IPD Sharing: NO. Countries: 1. Publications: 0.
Early Treatment Stratification Based on PET Scan Response to Chemotherapy in Patients With Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT01361191. IPD Sharing: Not stated. Countries: 1. Publications: 0.
JY231(JY231) Injection for the Treatment of Relapsed or Refractory B Cell Lymphoma/ Leukemia
ClinicalTrials.gov study NCT06678282. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Clinical Study of of RN1701 Injection in the Treatment of Relapsed/Refractory B-Cell Lymphomas
ClinicalTrials.gov study NCT07316920. IPD Sharing: NO. Countries: 1. Publications: 0.
Application of Zanubrutinib-based Combination Regimens in the Treatment of Newly-diagnosed Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT07371923. IPD Sharing: NO. Countries: 1. Publications: 0.
CD22 CAR T-cells to Extend Remission Following Commercial CD19 CAR T-cells in Children, Adolescents, and Adults With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT07328503. IPD Sharing: YES. Countries: 1. Publications: 0.
An Early Clinical Study Evaluating the Safety and Efficacy of AcNK-Sup003 Cell Injection in the Treatment of Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT06693973. IPD Sharing: YES. Countries: 1. Publications: 0.
Study of Canfosfamide in Refractory or Relapsed Mantle Cell, Diffuse Large B Cell Lymphoma and Multiple Myeloma
ClinicalTrials.gov study NCT01148108. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Prospective, Observational Cohort Study on the Clinical Impact of Novel Monoclonal Antibodies in B-cell Non-Hodgkin Lymphoma in Italian Clinical Practice
ClinicalTrials.gov study NCT06008691. IPD Sharing: Not stated. Countries: 1. Publications: 0.
AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas
ClinicalTrials.gov study NCT06340737. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Anti CD19 Gene Therapy for B-cell Lymphoma
ClinicalTrials.gov study NCT07211048. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy/Safety of Frontline Alemtuzumab (Campath, MabCampath) vs Chlorambucil in Patients With Progressive B-Cell Lymphocytic Leukemia
ClinicalTrials.gov study NCT00046683. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Hepatitis B Vaccination in HIV-infected Adults With Low CD4 Cell Counts
ClinicalTrials.gov study NCT02732054. IPD Sharing: NO. Countries: 1. Publications: 0.
INS, B Cells and Microbiota
ClinicalTrials.gov study NCT04924712. IPD Sharing: NO. Countries: 1. Publications: 0.
A Clinical Study of Allogenic CD19-CAR-T in the Treatment of R/R B-Cell Hematologic Malignancies
ClinicalTrials.gov study NCT07316907. IPD Sharing: NO. Countries: 1. Publications: 0.
Study to Evaluate Loncastuximab Tesirine With Rituximab Versus Immunochemotherapy in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT04384484. IPD Sharing: NO. Countries: 21. Publications: 0.
Study Comparing Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care Chemotherapy for Older Adults With Newly Diagnosed Philadelphia-negative B-cell Precursor Acute Lymphob
ClinicalTrials.gov study NCT04994717. IPD Sharing: YES. Countries: 32. Publications: 0.
A Study of AZD0486 in Subjects With B-Cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT04594642. IPD Sharing: YES. Countries: 5. Publications: 0.
CD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory B-Lineage Leukaemia / Lymphoma - A Feasibility Protocol
ClinicalTrials.gov study NCT05648019. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.